Coxsackievirus

Coxsackievirus

Electron micrograph of Coxsackie B4 virus

Coxsackievirus is a member of the Picornaviridae family, which includes small, non-enveloped viruses with a single-stranded RNA genome. These viruses are part of the genus Enterovirus, which also includes poliovirus and echovirus. Coxsackieviruses are divided into two groups: Group A and Group B, based on their pathogenicity in mice.

Classification

Coxsackieviruses are classified into two groups:

• Group A Coxsackieviruses: These viruses are known to cause diseases such as herpangina, hand, foot, and mouth disease, and acute hemorrhagic conjunctivitis.
• Group B Coxsackieviruses: These are associated with pleurodynia, myocarditis, pericarditis, and meningitis.

Pathogenesis

Coxsackieviruses are transmitted primarily via the fecal-oral route, although respiratory droplets can also spread the virus. After entering the body, the virus replicates in the oropharynx and gastrointestinal tract. It can then spread to other organs, including the heart, liver, and central nervous system.

Clinical Manifestations

The clinical manifestations of Coxsackievirus infections vary depending on the group and serotype of the virus:

• Group A Coxsackieviruses: Typically cause herpangina, characterized by fever, sore throat, and vesicular lesions on the soft palate. They are also responsible for hand, foot, and mouth disease, which presents with fever, sore throat, and a rash on the hands, feet, and mouth.
• Group B Coxsackieviruses: Known for causing pleurodynia (also known as Bornholm disease), which presents with sudden onset of chest or abdominal pain. They can also cause myocarditis and pericarditis, leading to chest pain, arrhythmias, and heart failure.

Diagnosis

Diagnosis of Coxsackievirus infection is primarily clinical, based on the characteristic symptoms. Laboratory confirmation can be achieved through:

• PCR testing of throat swabs, stool samples, or cerebrospinal fluid.
• Serology to detect specific antibodies against Coxsackievirus.

Treatment

There is no specific antiviral treatment for Coxsackievirus infections. Management is supportive and includes:

• Analgesics and antipyretics for pain and fever.
• Intravenous fluids for dehydration.
• Monitoring and supportive care for severe cases, such as myocarditis.

Prevention

Preventive measures include:

• Good hygiene practices, such as handwashing.
• Avoiding close contact with infected individuals.
• Disinfection of contaminated surfaces.

Related pages

• Enterovirus
• Picornaviridae
• Hand, foot, and mouth disease
• Myocarditis